Answers are grounded in this paper and cite their sources.
Hepatitis C virus (HCV) is one of the major causes of liver disease and a potential cause of substantial morbidity and mortality worldwide. HCV genotype 4 is responsible for more than 90% of chronic HCV infection in Egypt. Aim: estimation of the response rate and detection of the effect of treatment of CHC patients on degree of fibrosis. Patients and method: 90 patients included, 30 receving interferon containing regimen and 60 receiving interferon free. Conclusion: DAAS make a revolution in HCV treatment.
No takes yet. Share an insight, caveat, or question.
Motawea et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: